In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) closed at $16.75 up 2.45% from its previous closing price of $16.35. In other words, the price has increased by $2.45 from its previous closing price. On the day, 0.64 million shares were traded. CNTA stock price reached its highest trading level at $17.0 during the session, while it also had its lowest trading level at $15.49.
Ratios:
For a deeper understanding of Centessa Pharmaceuticals plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 21.52 and its Current Ratio is at 21.52. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on September 20, 2024, Upgraded its rating to Overweight and sets its target price to $26 from $11 previously.
On September 19, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $33.
On July 18, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $14.Oppenheimer initiated its Outperform rating on July 18, 2024, with a $14 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 26 ’24 when Weinhoff Gregory M sold 10,000 shares for $17.04 per share. The transaction valued at 170,399 led to the insider holds 183,266 shares of the business.
Weinhoff Gregory M bought 10,000 shares of CNTA for $168,000 on Dec 26 ’24. On Dec 20 ’24, another insider, SAHA SAURABH, who serves as the Chief Executive Officer of the company, sold 55,000 shares for $17.44 each. As a result, the insider received 959,057 and left with 520,661 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 2208403712 and an Enterprise Value of 1504503808. For the stock, the TTM Price-to-Sale (P/S) ratio is 319.15 while its Price-to-Book (P/B) ratio in mrq is 4.42. Its current Enterprise Value per Revenue stands at 219.539 whereas that against EBITDA is -9.327.
Stock Price History:
Over the past 52 weeks, CNTA has reached a high of $18.97, while it has fallen to a 52-week low of $6.65. The 50-Day Moving Average of the stock is 0.27%, while the 200-Day Moving Average is calculated to be 31.67%.
Shares Statistics:
For the past three months, CNTA has traded an average of 525.78K shares per day and 474720 over the past ten days. A total of 131.66M shares are outstanding, with a floating share count of 90.14M. Insiders hold about 31.53% of the company’s shares, while institutions hold 51.11% stake in the company. Shares short for CNTA as of 1734048000 were 3633001 with a Short Ratio of 6.91, compared to 1731628800 on 2438816. Therefore, it implies a Short% of Shares Outstanding of 3633001 and a Short% of Float of 3.3800002000000005.
